Yoshihiro Inamoto

Hematology | Oncology

825 Eastlake Ave E
Seattle, WA 98109

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 247 publications

Letermovir coadministration and tacrolimus concentration-to-dose ratios before and after intravenous-to-oral conversion in allogeneic hematopoietic stem cell transplant recipients receiving isavuconazole.

Letermovir coadministration and tacrolimus concentration-to-dose ratios before and after intravenous-to-oral conversion in allogeneic hematopoietic stem cell transplant recipients receiving isavuconazole.

Journal: Japanese journal of clinical oncology

Published: July 21, 2026

Toward Better Response Assessment of Cutaneous Chronic Graft-Versus-Host Disease: A Report from the National Institutes of Health Consensus Project Task Force.

Toward Better Response Assessment of Cutaneous Chronic Graft-Versus-Host Disease: A Report from the National Institutes of Health Consensus Project Task Force.

Journal: Transplantation and cellular therapy

Published: November 14, 2025

Comparison of One-Year Adverse Events Between First- and Second-Generation Bruton's Tyrosine Kinase Inhibitors: A Retrospective Study.

Comparison of One-Year Adverse Events Between First- and Second-Generation Bruton's Tyrosine Kinase Inhibitors: A Retrospective Study.

Journal: Cureus

Published: October 30, 2025

Advances in treatment of chronic graft-versus-host disease.

Advances in treatment of chronic graft-versus-host disease.

Journal: International journal of hematology

Published: September 19, 2025

International Survey for Antiemetics in Hematopoietic Stem Cell Transplantation in the APBMT Centers.

International Survey for Antiemetics in Hematopoietic Stem Cell Transplantation in the APBMT Centers.

Journal: Blood cell therapy

Published: September 01, 2025

Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron era.

Severe and/or prolonged COVID-19 in hematologic diseases: clinical implications before and during the omicron era.

Journal: Frontiers in oncology

Published: August 17, 2025

Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study.

Long-term follow-up of belumosudil as second or subsequent line of therapy for steroid-dependent/resistant cGVHD: clinical outcomes from a Japanese study.

Journal: Bone marrow transplantation

Published: August 14, 2025

Overview

Overview

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: August 06, 2025

Early administration of calcineurin inhibitors limits tolerogenic effect of PTCy in allogeneic hematopoietic transplant.

Early administration of calcineurin inhibitors limits tolerogenic effect of PTCy in allogeneic hematopoietic transplant.

Journal: Blood

Published: July 24, 2025

A win ratio approach for comparing graft-versus-host disease-free, relapse-free survival among alternative donors.

A win ratio approach for comparing graft-versus-host disease-free, relapse-free survival among alternative donors.

Journal: British journal of haematology

Published: April 25, 2025

Valemetostat Therapy for Relapsed Adult T-Cell Leukemia/Lymphoma After Allogeneic Hematopoietic Stem Cell Transplantation.

Valemetostat Therapy for Relapsed Adult T-Cell Leukemia/Lymphoma After Allogeneic Hematopoietic Stem Cell Transplantation.

Journal: Hematological oncology

Published: April 19, 2025

The optimal conversion ratio of tacrolimus switching from intravenous to oral tacrolimus administration in hematopoietic cell transplantation patients receiving posaconazole prophylaxis with and without letermovir.

The optimal conversion ratio of tacrolimus switching from intravenous to oral tacrolimus administration in hematopoietic cell transplantation patients receiving posaconazole prophylaxis with and without letermovir.

Journal: Japanese journal of clinical oncology

Published: April 17, 2025

Showing 1-12 of 247

Last Updated: 09/26/2026